Commentary

Re-envisioning psychosis: A new language for clinical practice

Author and Disclosure Information

 

References

Table 1

The ‘logic’ of schizoaffective disorder applied to anxiety and OCD

Symptom course‘Primary’ feature‘Secondary’ featureDiagnosis
2 weeks of ≥2 psychotic symptoms outside of a major mood episode plus a manic or depressed episode2 weeks of psychotic and negative symptoms2 weeks of low mood or anhedonia or 1 week of elevated or expansive moodSchizoaffective disorder
1 month of social anxiety and avoidance outside of a major mood episode plus a manic or depressed episode1 month of social anxiety and avoidance2 weeks of low mood or anhedonia or 1 week of elevated or expansive mood‘Socio-anxious-affective disorder’*
1 month of obsessions and compulsions outside of a major mood episode plus a manic or depressed episode1 month of obsessions and compulsions2 weeks of low mood or anhedonia or 1 week of elevated or expansive mood‘Obsessocompulso-affective disorder’*
OCD: obsessive-compulsive disorder
* These diagnoses are hypothetical disorders used to illustrate how the criteria used to define schizoaffective disorder subsume other types of symptoms

A continuum approach

As a way out of this inductive logic trap, we suggest the following statements as evidence-based and clinically realistic ways of approaching psychosis assessment.

‘Normal sadness’ and ‘normal psychosis’ are equivalent. The DSM-IV-TR description of major depressive disorder, states that “periods of sadness are inherent aspects of the human experience.”12 However, descriptions of psychosis rarely reflect that psychotic-like experiences are quite common13-19 and easily induced in otherwise healthy people.20 Psychotic symptoms are widely described as being genetically linked to normally distributed personality traits.21-24 Finally, research on risk for developing chronic psychosis has identified that most patients who develop attenuated psychotic symptoms do not experience them chronically.25-28 Together, these data argue strongly for a concept of psychosis as common and continuously distributed across large groups.

A psychosis screen can be much more than ‘+/- AH/VH/PI.’ We reject the idea that psychotic phenomena are fundamentally different from “normal” occurrences such as imagined or inner speech, perceptual fluctuations, distorted or rigid beliefs, or inability to accurately express one’s emotional state. Yet abnormal perception, affect flattening, and delusions often are viewed as “really weird,” which suggests most people never experience these phenomena, only “affected” people. This easily can lead to cognitive errors that associate psychosis as a state of mind that is fundamentally different from non-psychosis. In fact, DSMIV-TR categorizes the presence of persistent psychotic symptoms as evidence of disorder until proven otherwise.3

We feel that this simplistic language describing psychosis as inherently pathological ignores the clinical richness of psychotic experience. In our experience, many individuals who have been diagnosed with chronic psychosis have never been asked:

  • about the timing, intensity, and character of their abnormal sensory experiences29
  • how their beliefs and schemas affect day-to-day behavior and choices
  • if their psychotic symptoms are bothersome or troubling.

We worry that a person experiencing impairing psychotic symptoms could become overshadowed by all-or-none assumptions about the symptoms themselves.

We propose Table 2 as a guideline for approaching psychotic symptoms as expressions along a continuum of experience, one that shares much in common with recent well-developed biopsychosocial models of psychotic phenomena.30 In our view, this allows for a therapeutic alliance that focuses on patient recovery, as opposed to seeing psychotic symptoms as the only treatment targets. By moving beyond all-or-none myths and approaching psychosis as a continuum with normal experience, we believe that patient recovery can become a realistic goal.

Table 2

Revising the clinical language of psychosis to separate presence from pathology

SymptomContinuumAttenuated experiencePathological experience (‘disorder’)Psychotherapeutic intervention
Paranoid ideation/delusionsSchematization and testing of environmental information
  • referential thinking
  • suspiciousness
  • negative attitudes of others
  • confusion about accuracy of thoughts
  • feelings of special purpose or meaning
  • loss of control over own thoughts
  • frequent
  • preoccupying
  • leads to maladaptive behaviors
  • encourage curiosity about beliefs, evidence gathering, and alternative hypothesis testing
  • design new and adaptive safety behaviors
  • develop individual formulation of experience
HallucinationHigher order sensory processing and self/other discrimination
  • perceptual changes
  • increased sensitivity to light and sound
  • senses ‘playing tricks’
  • frequent
  • intrusive
  • distressing
  • conviction about external source
  • leads to maladaptive behaviors
  • discuss phenomenon as exaggeration of normal brain function
  • focus on socially appropriate coping skills (eg, talking into cell phone to have a ‘conversation’)
  • develop individual formulation of experience
Disorganized speech / ‘thought disorder’Social pragmatics and conceptual linking
  • difficulty ‘getting point across’
  • little insight
  • little attentional control
  • emphasize social appropriateness of linearity and tangentiality
  • encourage circumstantial thinking as a creative outlet
Source:
Bechdolf A, Phillips LJ, Francey SM, et al. Recent approaches to psychological interventions for people at risk of psychosis. Eur Arch Psychiatry Clin Neurosci. 2006;256(3):159-173.
Bentall RP, Fernyhough C. Social predictors of psychotic experiences: specificity and psychological mechanisms. Schizophr Bull. 2008;34(6):1012-1020.
French P, Morrison AP. Early detection and cognitive therapy for people at high risk of developing psychosis: a treatment approach. West Sussex, United Kingdom: John Wiley and Sons; 2004.
Christodoulides T, Dudley R, Brown S, et al. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series. Psychol Psychother. 2008;81(Pt 2):199-207.
Davis LW, Ringer JM, Strasburger AM, et al. Participant evaluation of a CBT program for enhancing work function in schizophrenia. Psychiatr Rehabil J. 2008;32(1):55-58.
Jackson HJ, McGorry PD, Killackey E, et al. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus befriending for first-episode psychosis: the ACE project. Psychol Med. 2008;38(5):725-735.
Lecomte T, Leclerc C, Corbiere M, et al. Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. J Nerv Ment Dis. 2008;196(12):866-875.
Loewy RL, Johnson JK, Cannon TD. Self-report of attenuated psychotic experiences in a college population. Schizophr Res. 2007; 93(1-3):144-151.
Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703-715.
Mitchell AJ. CBT for psychosis. Br J Psychiatry. 2004;185:438; author reply 438.
Rathod S, Kingdon D, Weiden P, et al. Cognitive-behavioral therapy for medication-resistant schizophrenia: a review. J Psychiatr Pract. 2008;14(1):22-33.
Wright JH, Kingdon D, Turkington D, et al. Cognitive-behavior therapy for severe mental illness. Arlington, VA: American Psychiatric Publishing, Inc.; 2008.

Recommended Reading

Late-Life Psychosis Mimics Schizophrenia
MDedge Psychiatry
Vital Signs: Antipsychotics Were the Top Therapeutic Class in 2009
MDedge Psychiatry
New Data Blur Typical-Atypical Drug Distinctions
MDedge Psychiatry
Consider Carcinogenicity of Psychotropics
MDedge Psychiatry
As in Adults, Most Adolescents Respond Early to Aripiprazole
MDedge Psychiatry
Schizophrenia in older adults
MDedge Psychiatry
Hallucinogen sequelae
MDedge Psychiatry
Should you order genetic testing to identify how patients metabolize antipsychotics?
MDedge Psychiatry
Uncooperative and manic
MDedge Psychiatry
The psychotic pot smoker
MDedge Psychiatry